On May 28, I-ACT for Children held a virtual workshop with regulators, biopharma developers and experts on the front lines of treating children with COVID-19. Speakers shared the latest on the clinical presentation of COVID-19 in children, the state of COVID-19 therapeutic research and innovative approaches to collecting the data required to advance safe and effective COVID-19 therapies for children.